🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to investigate safety and tolerabili...
Status
Completed
Location
The Medicines Evaluation Unit
Start Date
2017-05-18
Trial ID
NCT03135899
Certain lung disease medications can influence diagnostic tests and researc...
Status
Completed
Location
University of Saskatchewan
Start Date
2008-01
Trial ID
NCT00605410
Treatments Being Tested
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Colorado Allergy and Asthma Centers
Start Date
2015-12
Trial ID
NCT02624505
Treatments Being Tested
The study compares Buventol® Easyhaler® and Bufomix® Easyhaler® to the curr...
Status
Completed
Location
Helsinki University Hospital
Start Date
2021-11-11
Trial ID
NCT05084222
This study is a cross-sectional study to evaluate the relationship between ...
Status
Unknown
Location
SMG-SNU Boramae Medical Center
Start Date
2019-03-21
Trial ID
NCT03509259
Many acute and chronical medical conditions, such as, shock, sepsis, diabet...
Status
Terminated
Location
University Hospital Linköping
Start Date
2019-04-01
Trial ID
NCT04777383
Treatments Being Tested
Asthma and exercise induced bronchoconstriction (EIB) represent an importan...
Status
Completed
Location
Olympiatoppen
Start Date
2020-12-01
Trial ID
NCT04275648
Treatments Being Tested
Exposure to allergens changes the way the airway responds to some stimuli (...
Status
Completed
Location
University of Saskatchewan
Start Date
2012-10
Trial ID
NCT01699594
Treatments Being Tested
Asthma is the most common chronic lung disease in children. It affects more...
Status
Recruiting
Location
CHU de Montpellier
Start Date
2023-09-07
Trial ID
NCT05734261
Treatments Being Tested
The purpose of this study is to compare the effects of SB-480848 with place...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08
Trial ID
NCT00368576
Treatments Being Tested